November 29, 2017

A Health Check of Europe’s Mutual Fund Market

by Jake Moeller

How does one ascertain the health of the pan-European mutual fund industry? While I’m able to control lifestyle factors—such as levels of exercise and diet—that may affect my health, the mutual fund market is an amorphous body of assets and liabilities reflecting an incalculable collection of differing objectives. The lifestyle factors this industry faces include not only prevailing market conditions but the aggregated expectations of all its participants.

Lifestyle factors have been a challenge

Recently, there has been plenty of challenging lifestyle factors for our industry. One can go back to “Black Monday” in the summer of 2015 and the subsequent commodity price collapse. We have had the Brexit referendum and the Donald Trump presidential election, both providing further uncertainty. Underlying regulatory initiatives also have directly affected the European mutual fund industry. Consider fund managers’ touch points to MIFIDII, EMIR, Basel III, Solvency II, Shareholdings Disclosure, AIFMD, and Dodd Frank as well as ongoing ESMA and FCA pronouncements.

Fund flows are a barometer of health

Flows are for me a critical measure of the fund industry’s health. It is difficult to conclude that on this metric alone, the industry is not in anything but robust health. According to the most recent quarterly Thomson Reuters Lipper data, the first nine months of 2017 have set the stage for a new record year in the pan-European fund industry.

Exhibit 1. Historical Assets Under Management of European Mutual Fund Market (to September 30, 2017 in € trillion)

Review of the European Fund Industry, September 2017

Source: Thomson Reuters Lipper.

Assets under management in Europe stood at €10.2 trillion at the end of September, with the U.K. encompassing nearly 20% of that total. We have been making good progress against the U.S. market, which stands at some U$20 trillion. Additionally, the European fund industry has enjoyed record net inflows of €614.2 billion (with the U.K. representing around 9% of that) for 2017 so far, far above the previous watermark recorded (€386 billion for all of 2015). The number for the first nine months of 2017 is well above the long-term 12-month average of €166 billion.

A good blend of asset growth is a healthy sign

Investors too are showing a healthy regard for differing asset classes. Perhaps not as risk-averse as you may expect in light of the challenging lifestyle factors mentioned above, equities are still buoyant. This is reflected in the flows into Lipper fund classifications: Equity Global (+€51.3 billion) is the best selling sector for the year 2017 so far, followed by Bond Global (+€38.0 billion), Bond Global USD Hedged (+€33.9 billion), and Bond EUR Short Term (+€31.2 billion) as well as Bond Emerging Markets Global in Hard Currencies (+€27.5 billion).

There has also been considerable product consolidation in Europe with respect to new fund launches. Some 1,400 funds have been launched in Europe and the U.K. for the year to date, a figure nearly 50 percentage points down from the launches for 2012. This undoubtedly reflects somewhat healthy competitive elements in the industry.

In light of the very challenging lifestyle events Europe’s fund market is facing in 2017 and beyond, it strikes me that it in pretty good shape with a healthy outlook for the future.

 


Thomson Reuters Lipper delivers data on more than 265,000 collective investments in 61 countries. Find out more.

Disclaimer: 
This material is provided for as market commentary and for educational purposes only and does not constitute investment research or advice. Thomson Reuters cannot be held responsible for any direct or incidental loss resulting from applying any of the information provided in this publication or from any other source mentioned. Please consult with a qualified professional for financial advice.

Article Keywords

Get In Touch

Subscribe